CDKN2A and lung adenocarcinoma: Genomic data analyses evidenced that EGFR and KRAS mutations, the most common aberrations in lung adenocarcinoma, are extremely rare in pure SCC, while alterations in the FGFR kinase family, PIK3CA, CDKN2A and RB1 pathways are common [131,132].